Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 9,885,449 | 8,020,136 | -1,865,313 | 131,476 | 227,692 | 21.01% | +96,215 |
| Kymera Therapeutics, Inc.(KYMR) | 5,858,262 | 5,377,362 | -480,900 | 149,151 | 216,170 | 19.95% | +67,019 |
| Korro Bio, Inc. | 1,119,292 | 1,119,292 | 0 | 53,648 | 100,736 | 9.30% | +47,089 |
| Q32 Bio, Inc. | 0 | 2,092,106 | +2,092,106 | 0 | 35,649 | 3.29% | +35,649 |
| Generation Bio, Co. | 8,279,484 | 8,279,484 | 0 | 13,661 | 33,698 | 3.11% | +20,036 |
| Aerovate Therapeutics, Inc. | 2,039,249 | 2,039,249 | 0 | 46,148 | 60,301 | 5.57% | +14,152 |
| Dianthus Therapeutics, Inc.(DNTH) | 236,979 | 186,979 | -50,000 | 2,465 | 5,609 | 0.52% | +3,145 |
| Vigil Neuroscience, Inc. | 5,836,874 | 5,836,874 | 0 | 19,729 | 19,904 | 1.84% | +175 |
| AvroBio, Inc. | 4,541,381 | 4,541,381 | 0 | 6,176 | 5,813 | 0.54% | -363 |
| Spero Therapeutics, Inc. | 1,013,438 | 607,613 | -405,825 | 1,490 | 1,045 | 0.10% | -445 |
| Xilio Therapeutics, Inc. | 2,759,344 | 992,912 | -1,766,432 | 1,518 | 1,072 | 0.10% | -445 |
| Replimune Group, Inc.(REPL) | 2,098,300 | 2,098,300 | 0 | 17,689 | 17,143 | 1.58% | -546 |
| Ikena Oncology, Inc. | 5,018,178 | 5,018,178 | 0 | 9,886 | 7,126 | 0.66% | -2,760 |
| Day One Biopharmaceuticals, Inc. COM | 7,608,394 | 6,430,257 | -1,178,137 | 111,083 | 106,228 | 9.80% | -4,855 |
| Disc Medicine, Inc.(IRON) | 2,555,172 | 2,287,233 | -267,939 | 147,587 | 142,403 | 13.14% | -5,184 |
| Akero Therapeutics, Inc. | 359,251 | 0 | -359,251 | 8,389 | 0 | — | -8,389 |
| Third Harmonic Bio, Inc. | 10,907,859 | 10,907,859 | 0 | 119,659 | 102,970 | 9.50% | -16,689 |